Paclitaxel sensitivity of breast cancer cells requires efficient mitotic arrest and disruption of Bcl-xL/Bak interaction.
Breast Cancer Res Treat
; 133(3): 917-28, 2012 Jun.
Article
in En
| MEDLINE
| ID: mdl-22076480
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Paclitaxel
/
Bcl-2 Homologous Antagonist-Killer Protein
/
Bcl-X Protein
/
M Phase Cell Cycle Checkpoints
/
Antineoplastic Agents, Phytogenic
Type of study:
Diagnostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Breast Cancer Res Treat
Year:
2012
Document type:
Article
Affiliation country:
Spain